MAPT and Alzheimer disease: Remarkably, hTau is phosphorylated, during mitosis, such as to give the same immunoreactive pattern as hyperphosphorylated ‘pathological’ Tau in AD, using the antibodies anti-AT8, -Tau-1, -T46 and -PHF-1 (Preuss et al., 1995).